An in vitro human cell model screen for YK-4-279 responsiveness revealed a surprising hyperactivity of this compound in the P53 knock-out subline of the human colon carcinoma cell model RKO, resulting in an IC50 value in the lower nanomolar range. Here, TP53 is linked to colon carcinoma.